United States v. Nathaniel Williams

53 F.4th 825
CourtCourt of Appeals for the Fourth Circuit
DecidedNovember 17, 2022
Docket22-6464
StatusPublished
Cited by1 cases

This text of 53 F.4th 825 (United States v. Nathaniel Williams) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Nathaniel Williams, 53 F.4th 825 (4th Cir. 2022).

Opinion

USCA4 Appeal: 22-6464 Doc: 38 Filed: 11/17/2022 Pg: 1 of 15

PUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 22-6464

UNITED STATES OF AMERICA,

Petitioner - Appellee,

v.

NATHANIEL WILLIAMS,

Respondent - Appellant.

Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. W. Earl Britt, Senior District Judge. (5:21-hc-02244-BR)

Argued: September 14, 2022 Decided: November 17, 2022

Before RICHARDSON and HEYTENS, Circuit Judges, and MOTZ, Senior Circuit Judge.

Vacated and remanded by published opinion. Judge Heytens wrote the opinion, in which Senior Judge Motz joined. Judge Richardson wrote a dissenting opinion.

ARGUED: Jennifer Claire Leisten, OFFICE OF THE FEDERAL PUBLIC DEFENDER, Raleigh, North Carolina, for Appellant. Genna Danelle Petre, OFFICE OF THE UNITED STATES ATTORNEY, Raleigh, North Carolina, for Appellee. ON BRIEF: G. Alan DuBois, Federal Public Defender, OFFICE OF THE FEDERAL PUBLIC DEFENDER, Raleigh, North Carolina, for Appellant. Michael F. Easley, Jr., United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Raleigh, North Carolina, for Appellee. USCA4 Appeal: 22-6464 Doc: 38 Filed: 11/17/2022 Pg: 2 of 15

TOBY HEYTENS, Circuit Judge:

Federal prisoners on the cusp of being released may be civilly committed if they are

“presently suffering from a mental disease or defect as a result of which [their] release

would create a substantial risk” to the person or property of others. 18 U.S.C. § 4246(d).

Here, the primary question is whether—in making such a risk assessment—a court must

consider any terms of supervision that would govern the prisoner’s conduct post release.

The answer, we hold, is yes. And because the record offers no assurances the district court

appropriately considered the terms of Nathaniel Williams’ supervised release before

ordering him committed, we vacate the court’s order and remand for further proceedings.

I.

A.

Williams has long struggled with mental illness and a proclivity to violent outbursts.

In 2017, Williams assaulted a security guard in Portland, Oregon—a federal crime because

it happened at a Social Security office. See 18 U.S.C. § 111(a)(1). Williams pleaded guilty

and was sentenced to just over four years in prison, to be followed by three years of

supervised release. The sentencing court imposed 13 standard and 14 special conditions of

supervised release, including that Williams “must take all mental health medications that

are prescribed by [his] treating physician” and “must participate in a mental health

treatment program.” JA 128.

For several years, Williams did not fare well in federal custody. In March 2019, he

was transferred to a medical center in Minnesota after failing to take medication,

experiencing mania and hallucinations, and assaulting his cellmate. Even after the transfer,

2 USCA4 Appeal: 22-6464 Doc: 38 Filed: 11/17/2022 Pg: 3 of 15

Williams continued to rack up incident reports and failed to reliably take prescribed

medication. After more than a year of new incidents—and Williams’ formal request to

withdraw from voluntary mental health treatment—the government successfully petitioned

to have Williams hospitalized under 18 U.S.C. § 4245, which permits the involuntary

transfer of a federal prisoner who “is presently suffering from a mental disease or defect”

“to a suitable facility for care and treatment.” § 4245(a) & (d).

Having secured the involuntary hospitalization order, Bureau of Prisons officials

concluded Williams met the constitutional and regulatory criteria for involuntary

medication. See Washington v. Harper, 494 U.S. 210 (1990); 28 C.F.R. § 549.46(a)(5) &

(b). In June 2021, Williams began receiving monthly injections of Haldol, which

“psychiatrically stabilized” Williams and “remitt[ed]” his symptoms. JA 43, 47. Since

starting Haldol injections, Williams has engaged in no violent behavior.

Three months before Williams’ custodial sentence was set to expire, the Bureau of

Prisons transferred him to a specialized facility in North Carolina to assess whether he

could be safely released. The evaluating psychologist acknowledged that, at the time of

intake, Williams displayed no overt signs of a formal thought or mood disorder and his

medications had largely remitted his past symptoms. The evaluating psychologist, though,

concluded that releasing Williams would create a substantial risk of injury to people or

property because she thought Williams would stop taking his medication, which would, in

turn, render him dangerous to others.

3 USCA4 Appeal: 22-6464 Doc: 38 Filed: 11/17/2022 Pg: 4 of 15

B.

Less than two weeks before Williams’ scheduled release, the government asked a

district court in North Carolina (commitment court) to order him civilly committed. The

government’s request automatically stayed Williams’ release, see 18 U.S.C. § 4246(a), and

the commitment court held a hearing at which Williams, the evaluating psychologist, and

a psychiatrist selected by Williams testified. Williams also provided the judgment of the

sentencing court, which included the terms of his supervised release.

During the hearing, several points of common ground emerged. First, Williams

suffers from schizoaffective disorder, bipolar type, which is in partial or full remission.

Second, Williams has a history of seemingly indiscriminate acts of violence when

unmedicated. Third, while on his current medication—which he had been taking for more

than nine months on an involuntary basis at the time of the hearing—Williams poses no

substantial threat to others.

The issue thus came down to whether Williams was likely to continue taking his

medication if released. See JA 115 (commitment court stating, “I don’t think the

Government would dispute” that Williams is “not a danger as long as he complies with his

medication”). Williams acknowledged his past failures to take prescribed medication but

testified he enjoyed the effects of Haldol, wanted to keep taking it, and likely would be

reincarcerated if he failed to do so. By contrast, the evaluating psychologist concluded

Williams was unlikely to keep taking his medication if released, citing his earlier probation

violations, past inability to stick to medications, and lack of insight into the seriousness of

his mental illness.

4 USCA4 Appeal: 22-6464 Doc: 38 Filed: 11/17/2022 Pg: 5 of 15

After the parties presented their evidence, the commitment court asked whether it

could order Williams’ release under “conditions which would assure his lack of

dangerousness,” JA 116, and recessed the hearing so the parties could formulate positions

on the matter. When the hearing resumed, the parties agreed that a court considering

whether to halt a person’s release under Section 4246(d) may not impose new conditions

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Michael Hodge
Fourth Circuit, 2024

Cite This Page — Counsel Stack

Bluebook (online)
53 F.4th 825, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-nathaniel-williams-ca4-2022.